Literature DB >> 30170005

Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation.

Bikash Ranjan Sahoo1, Takuya Genjo1, Sarah J Cox2, Andrea K Stoddard2, G M Anantharamaiah3, Carol Fierke4, Ayyalusamy Ramamoorthy5.   

Abstract

Peptidic nanodiscs are useful membrane mimetic tools for structural and functional studies of membrane proteins, and membrane interacting peptides including amyloids. Here, we demonstrate anti-amyloidogenic activities of a nanodisc-forming 18-residue peptide (denoted as 4F), both in lipid-bound and lipid-free states by using Alzheimer's amyloid-beta (Aβ40) peptide as an example. Fluorescence-based amyloid fibrillation kinetic assays showed a significant delay in Aβ40 amyloid aggregation by the 4F peptide. In addition, 4F-encased lipid nanodiscs, at an optimal concentration of 4F (>20 μM) and nanodisc size (<10 nm), significantly affect amyloid fibrillation. A comparison of experimental results obtained from nanodiscs with that obtained from liposomes revealed a substantial inhibitory efficacy of 4F-lipid nanodiscs against Aβ40 aggregation and were also found to be suitable to trap Aβ40 intermediates. A combination of atomistic molecular dynamics simulations with NMR and circular dichroism experimental results exhibited a substantial change in Aβ40 conformation upon 4F binding through electrostatic and π-π interactions. Specifically, the 4F peptide was found to interfere with the central β-sheet-forming residues of Aβ40 through substantial hydrogen, π-π, and π-alkyl interactions. Fluorescence experiments and coarse-grained molecular dynamics simulations showed the formation of a ternary complex, where Aβ40 binds to the proximity of peptidic belt and membrane surface that deaccelerate amyloid fibrillation. Electron microscopy images revealed short and thick amyloid fibers of Aβ40 formed in the presence of 4F or 4F-lipid nanodsics. These findings could aid in the development of amyloid inhibitors as well as in stabilizing Aβ40 intermediates for high-resolution structural and neurobiological studies.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; beta-amyloid; membrane scaffold protein; nanodisc; protein aggregation

Mesh:

Substances:

Year:  2018        PMID: 30170005      PMCID: PMC6186505          DOI: 10.1016/j.jmb.2018.08.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  65 in total

Review 1.  Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity.

Authors:  Massimo Stefani
Journal:  FEBS J       Date:  2010-11       Impact factor: 5.542

2.  Spontaneous Lipid Nanodisc Fomation by Amphiphilic Polymethacrylate Copolymers.

Authors:  Kazuma Yasuhara; Jin Arakida; Thirupathi Ravula; Sudheer Kumar Ramadugu; Bikash Sahoo; Jun-Ichi Kikuchi; Ayyalusamy Ramamoorthy
Journal:  J Am Chem Soc       Date:  2017-12-05       Impact factor: 15.419

Review 3.  Mysterious oligomerization of the amyloidogenic proteins.

Authors:  Vladimir N Uversky
Journal:  FEBS J       Date:  2010-06-10       Impact factor: 5.542

4.  High-Affinity Binding of Monomeric but Not Oligomeric Amyloid-β to Ganglioside GM1 Containing Nanodiscs.

Authors:  Maren Thomaier; Lothar Gremer; Christina Dammers; Judith Fabig; Philipp Neudecker; Dieter Willbold
Journal:  Biochemistry       Date:  2016-11-18       Impact factor: 3.162

5.  Temperature-dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation.

Authors:  O Gursky; S Aleshkov
Journal:  Biochim Biophys Acta       Date:  2000-01-03

6.  Real-time monitoring of the aggregation of Alzheimer's amyloid-β via1H magic angle spinning NMR spectroscopy.

Authors:  Jian Wang; Tomoya Yamamoto; Jia Bai; Sarah J Cox; Kyle J Korshavn; Martine Monette; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2018-02-20       Impact factor: 6.222

7.  Amyloid-β adopts a conserved, partially folded structure upon binding to zwitterionic lipid bilayers prior to amyloid formation.

Authors:  Kyle J Korshavn; Anirban Bhunia; Mi Hee Lim; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2016-01-18       Impact factor: 6.222

Review 8.  The amyloid state and its association with protein misfolding diseases.

Authors:  Tuomas P J Knowles; Michele Vendruscolo; Christopher M Dobson
Journal:  Nat Rev Mol Cell Biol       Date:  2014-06       Impact factor: 94.444

9.  Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes.

Authors:  Sholpan Askarova; Xiaoguang Yang; James C-M Lee
Journal:  Int J Alzheimers Dis       Date:  2011-03-17

10.  I-TASSER server for protein 3D structure prediction.

Authors:  Yang Zhang
Journal:  BMC Bioinformatics       Date:  2008-01-23       Impact factor: 3.169

View more
  18 in total

1.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

2.  Zinc boosts EGCG's hIAPP amyloid Inhibition both in solution and membrane.

Authors:  Young-Ho Lee; Yuxi Lin; Sarah J Cox; Misaki Kinoshita; Bikash R Sahoo; Magdalena Ivanova; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-11-22       Impact factor: 3.036

3.  Amyloidosis Inhibition, a New Frontier of the Protein Corona.

Authors:  Pengyu Chen; Feng Ding; Rong Cai; Ibrahim Javed; Wen Yang; Zhenzhen Zhang; Yuhuan Li; Thomas P Davis; Pu Chun Ke; Chunying Chen
Journal:  Nano Today       Date:  2020-07-22       Impact factor: 20.722

4.  Single-Molecular Heteroamyloidosis of Human Islet Amyloid Polypeptide.

Authors:  Aleksandr Kakinen; Yanting Xing; Nuwan Hegoda Arachchi; Ibrahim Javed; Lei Feng; Ava Faridi; Alon M Douek; Yunxiang Sun; Jan Kaslin; Thomas P Davis; Michael J Higgins; Feng Ding; Pu Chun Ke
Journal:  Nano Lett       Date:  2019-08-29       Impact factor: 11.189

Review 5.  High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.

Authors:  Bikash R Sahoo; Sarah J Cox; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2020-04-17       Impact factor: 6.222

6.  Time-Dependent Lipid Dynamics, Organization and Peptide-Lipid Interaction in Phospholipid Bilayers with Incorporated β-Amyloid Oligomers.

Authors:  Wei Qiang; Katelynne E Doherty; Lukas M Klees; Yuto Tobin-Miyaji
Journal:  J Phys Chem Lett       Date:  2020-09-18       Impact factor: 6.475

7.  The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.

Authors:  C Roger White; Geeta Datta; Landon Wilson; Mayakonda N Palgunachari; G M Anantharamaiah
Journal:  Chem Phys Lipids       Date:  2019-01-29       Impact factor: 3.329

8.  Acetylation of Aβ40 Alters Aggregation in the Presence and Absence of Lipid Membranes.

Authors:  Albert W Pilkington; Jane Schupp; Morgan Nyman; Stephen J Valentine; David M Smith; Justin Legleiter
Journal:  ACS Chem Neurosci       Date:  2019-12-27       Impact factor: 4.418

Review 9.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

10.  Ion channel formation by N-terminally truncated Aβ (4-42): relevance for the pathogenesis of Alzheimer's disease.

Authors:  Abhijith G Karkisaval; Agueda Rostagno; Rustam Azimov; Deependra K Ban; Jorge Ghiso; Bruce L Kagan; Ratnesh Lal
Journal:  Nanomedicine       Date:  2020-06-10       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.